SCHEMBL8779816

SCHEMBL8779816

O=C(O)c1ccc(N=C=S)c(N=C=S)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NEU3 Q9UQ49 4/20 0.42
TSHR P16473 2/20 0.41
TP53 P04637 1/20 0.41
CA1 P00915 5/20 0.41
CA2 P00918 5/20 0.41
CA12 O43570 4/20 0.41
CA6 P23280 4/20 0.41
CA9 Q16790 4/20 0.41
CA4 P22748 3/20 0.41
CA7 P43166 3/20 0.41
CA14 Q9ULX7 3/20 0.41
KDM4E B2RXH2 2/20 0.41
POLB P06746 2/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
PTGS2 P35354 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.38
SIRT1 Q96EB6 1/20 0.38
SRD5A2 P31213 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28559554 0.86 TDP1 (0.34) TSHRPOLBGAAMAPTL3MBTL1
SCHEMBL2899363 0.85 NEU3 (0.45) NEU3TSHRTP53CA1CA2
SCHEMBL10470163 0.84 TSHR (0.53) NEU3TSHRTP53CA1CA2
SCHEMBL3399259 0.84 ALDH1A1 (0.46) NEU3TSHRKDM4EGAAMAPT
SCHEMBL3398382 0.84 TSHR (0.44) NEU3TSHRTP53CA1CA2
SCHEMBL10472433 0.84 TTR (0.41) NEU3TSHRTP53CA1CA2
SCHEMBL2919702 0.80 CA1 (0.57) TSHRCA1CA2CA12CA6
SCHEMBL6660393 0.77 PTPN1 (0.50) KDM4EPOLBMAPTSIRT1KMT2A
SCHEMBL455561 0.74 MIF (0.54) TSHRTP53CA1CA2CA12
SCHEMBL3398682 0.73 KDM4E (0.50) CA1CA2CA12CA9KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0635001-B1 SUBSTITUTED THIOUREAS AS BIFUNCTIONAL CHELATORS CYTOGEN CORP (US) 1997-08-20 EP disclosed
US-5585468-A MEDICAL DIAGNOSIS; TUMOR IMAGING CYTOGEN CORPORATION (US) 1996-12-17 US disclosed
US-5527885-A USEFUL FOR DELIVERING DRUGS OR RADIOISOTOPES TO TARGET ORGANS, TUMORS OR THROMBI IN VIVO CYTOGEN CORPORATION (US) 1996-06-18 US disclosed
EP-0635001-A1 SUBSTITUTED THIOUREAS AS BIFUNCTIONAL CHELATORS. CYTOGEN CORP (US) 1995-01-25 EP disclosed
US-5326856-A For radioimaging of organs or tumors CYTOGEN CORPORATION (US) 1994-07-05 US disclosed
WO-1993021151-A1 SUBSTITUTED THIOUREAS AS BIFUNCTIONAL CHELATORS CYTOGEN CORPORATION (US) 1993-10-28 WO disclosed